李
00950
李氏大藥廠
1.110
-0.025-2.20%Closed15:47 08/25 HKT
OPEN/PREV CLOSE1.235/1.120
TODAY RANGE1.235-1.370
VOL6.15M
MARKET CAP789.04M
52 WEEK RANGE0.990-2.641
AVG VOL (3M)629.52K
% TURNOVER1.04%
TURNOVER8.09M
P/E (TTM)8.584
% RANGE12.05%
EPS(TTM)0.156
P/E(FORWARD)10.764
P/B0.386
BVPS3.474
DIVIDEND0.045
P/S0.549
BETA--
DIV YIELD3.36%
FREE FLOAT MKT CAP789.04M
SHARES OUTSTANDING588.84M
NEXT EARNINGS08/24-08/28
FREE FLOAT588.84M
LOT SIZE500
EX-DATE05/27/2026
News
Press Releases
Financial Reports
Profile
Simply Wall St·05/22 22:40
Read This Before Considering Lee's Pharmaceutical Holdings Limited (HKG:950) For Its Upcoming HK$0.023 Dividend
Simply Wall St·09/18/2025 22:34
Lee's Pharmaceutical Holdings Limited's (HKG:950) Shares Climb 27% But Its Business Is Yet to Catch Up
Simply Wall St·09/03/2025 00:31
We Think Lee's Pharmaceutical Holdings' (HKG:950) Profit Is Only A Baseline For What They Can Achieve
Simply Wall St·08/28/2025 23:09
Lee's Pharmaceutical Holdings (HKG:950) Is Due To Pay A Dividend Of HK$0.022
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.